SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C.
20549
Report of Foreign Private Issuer
Pursuant to Rule 13a-16 or 15d-16
of the Securities Exchange Act of
1934
May 07, 2019
Commission
File Number 001-14978
SMITH & NEPHEW
plc
(Registrant's
name)
Building
5, Croxley
Park,
Hatters Lane,
Watford, Hertfordshire, WD18 8YE,
England
(Address
of registrant's principal executive offices)
[Indicate
by check mark whether the registrant files or will file
annual
reports
under cover Form 20-F or Form 40-F.]
Form
20-F
X
Form 40-F
---
---
[Indicate
by check mark if the registrant is submitting the Form 6-K
in
paper
as permitted by Regulation S-T Rule 101(b)(1).]
Yes
No X
---
---
[Indicate
by check mark if the registrant is submitting the Form 6-K
in
paper
as permitted by Regulation S-T Rule 101(b)(7).]
Yes
No X
---
---
[Indicate
by check mark whether by furnishing the information
contained
in this
Form, the registrant is also thereby furnishing information to
the
Commission
pursuant to Rule 12g3-2 (b) under the Securities Exchange Act
of
1934.]
Yes
No X
---
---
If
"Yes" is marked, indicate below the file number assigned to
the
registrant
in connection with Rule 12g3-2 (b) : 82- n/a.
7 May 2019
Smith & Nephew plc
Change of Registered Office
Smith & Nephew plc (LSE:SN, NYSE:SNN), the global medical
technology business, announces that with effect from Friday 3 May
2019, the location of its registered office has changed
to: Building 5, Croxley Park,
Hatters Lane, Watford, Hertfordshire, WD18 8YE, England.
Susan Swabey
Company Secretary
Smith & Nephew plc
Tel: 01923 477216
ENDS
Enquiries
Investors
Andrew
Swift
+44 (0) 20 7960 2285
Smith & Nephew
Media
Charles
Reynolds
+44 (0) 1923 477314
Smith & Nephew
About Smith & Nephew
Smith & Nephew is a portfolio medical technology business with
leadership positions in Orthopaedics, Advanced Wound Management and
Sports Medicine. Smith & Nephew has more than 16,000 employees
and a presence in more than 100 countries. Annual sales in 2018
were $4.9 billion. Smith & Nephew is a member of the FTSE100
(LSE:SN, NYSE:SNN). For more information about Smith & Nephew,
please visit our corporate website www.smith-nephew.com and
follow us on Twitter, LinkedIn or Facebook.
SIGNATURES
Pursuant
to the requirements of the Securities Exchange Act of 1934, the
registrant has duly caused this report to be signed on its behalf
by the undersigned thereunto duly authorized.
Smith
& Nephew Plc
(Registrant)
Date: May
07, 2019
By: /s/
Susan Swabey
-----------------
Susan
Swabey
Company
Secretary